These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 17279622

  • 1. Covalent and noncovalent modifications induce allosteric binding behavior in a monoclonal antibody.
    Blake RC, Li X, Yu H, Blake DA.
    Biochemistry; 2007 Feb 13; 46(6):1573-86. PubMed ID: 17279622
    [Abstract] [Full Text] [Related]

  • 2. Novel monoclonal antibodies with specificity for chelated uranium(VI): isolation and binding properties.
    Blake II RC, Pavlov AR, Khosraviani M, Ensley HE, Kiefer GE, Yu H, Li X, Blake DA.
    Bioconjug Chem; 2004 Feb 13; 15(5):1125-36. PubMed ID: 15366969
    [Abstract] [Full Text] [Related]

  • 3. Allosteric binding properties of a monoclonal antibody and its Fab fragment.
    Blake RC, Delehanty JB, Khosraviani M, Yu H, Jones RM, Blake DA.
    Biochemistry; 2003 Jan 21; 42(2):497-508. PubMed ID: 12525177
    [Abstract] [Full Text] [Related]

  • 4. Identification of important residues in metal-chelate recognition by monoclonal antibodies.
    Delehanty JB, Jones RM, Bishop TC, Blake DA.
    Biochemistry; 2003 Dec 09; 42(48):14173-83. PubMed ID: 14640685
    [Abstract] [Full Text] [Related]

  • 5. On molecular recognition of an uranyl chelate by monoclonal antibodies.
    Teulon JM, Odorico M, Chen SW, Parot P, Pellequer JL.
    J Mol Recognit; 2007 Dec 09; 20(6):508-15. PubMed ID: 18080996
    [Abstract] [Full Text] [Related]

  • 6. Unidirectional potentiation of binding between two anti-FBP MAbs: evaluation of the involved mechanisms.
    Casalini P, Mezzanzanica D, Valota O, Adobati E, Tomassetti A, Colnaghi MI, Canevari S.
    J Cell Biochem; 1995 May 09; 58(1):47-55. PubMed ID: 7642722
    [Abstract] [Full Text] [Related]

  • 7. Effect of bivalent interaction upon apparent antibody affinity: experimental confirmation of theory using fluorescence photobleaching and implications for antibody binding assays.
    Kaufman EN, Jain RK.
    Cancer Res; 1992 Aug 01; 52(15):4157-67. PubMed ID: 1638531
    [Abstract] [Full Text] [Related]

  • 8. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
    Ochs HR, Smith TW.
    J Clin Invest; 1977 Dec 01; 60(6):1303-13. PubMed ID: 914999
    [Abstract] [Full Text] [Related]

  • 9. The equilibrium constant for the interaction between a monoclonal Fab fragment and an influenza virus neuraminidase.
    Jackson DC, Howlett GJ, Nestorowicz A, Webster RG.
    J Immunol; 1983 Mar 01; 130(3):1313-6. PubMed ID: 6822736
    [Abstract] [Full Text] [Related]

  • 10. H-2 expression by lymphoid cells of different mouse strains: quantitative interaction of H-2 with monoclonal antibodies and their Fab fragments.
    Hackett CJ, Askonas BA.
    Immunology; 1981 Feb 01; 42(2):207-15. PubMed ID: 7461728
    [Abstract] [Full Text] [Related]

  • 11. Genetic and fluorescence studies of affinity maturation in related antibodies.
    Pauyo T, Hilinski GJ, Chiu PT, Hansen DE, Choi YJ, Ratner DI, Shah-Mahoney N, Southern CA, O'Hara PB.
    Mol Immunol; 2006 Mar 01; 43(7):812-21. PubMed ID: 16137768
    [Abstract] [Full Text] [Related]

  • 12. High-affinity uranyl-specific antibodies suitable for cellular imaging.
    Reisser-Rubrecht L, Torne-Celer C, Rénier W, Averseng O, Plantevin S, Quéméneur E, Bellanger L, Vidaud C.
    Chem Res Toxicol; 2008 Feb 01; 21(2):349-57. PubMed ID: 18154273
    [Abstract] [Full Text] [Related]

  • 13. Production of Fab fragments of monoclonal antibodies using polyelectrolyte complexes.
    Dainiak MB, Muronetz VI, Izumrudov VA, Galaev IY, Mattiasson B.
    Anal Biochem; 2000 Jan 01; 277(1):58-66. PubMed ID: 10610689
    [Abstract] [Full Text] [Related]

  • 14. [Cooperative effects during interaction of monoclonal antibodies with insulin dimers].
    Rubtsova MIu, Cherednikova TV, Susova MB, Gavrilova EM, Egorov AM.
    Biokhimiia; 1987 Sep 01; 52(9):1531-8. PubMed ID: 3315010
    [Abstract] [Full Text] [Related]

  • 15. Measurement of the functional affinity constant of a monoclonal antibody for cell surface receptors using kinetic exclusion fluorescence immunoassay.
    Xie L, Mark Jones R, Glass TR, Navoa R, Wang Y, Grace MJ.
    J Immunol Methods; 2005 Sep 01; 304(1-2):1-14. PubMed ID: 16098983
    [Abstract] [Full Text] [Related]

  • 16. Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats.
    Proksch JW, Gentry WB, Owens SM.
    J Pharmacol Exp Ther; 2000 Mar 01; 292(3):831-7. PubMed ID: 10688594
    [Abstract] [Full Text] [Related]

  • 17. Potential of mean force for Syrian hamster prion epitope protein--monoclonal fab 3f4 antibody interaction studies.
    Wang YT, Su ZY, Liao JM, Chen CL.
    Eur J Med Chem; 2009 Sep 01; 44(9):3504-8. PubMed ID: 19304354
    [Abstract] [Full Text] [Related]

  • 18. Binding properties of monoclonal anti-IgG antibodies: analysis of binding curves in monoclonal antibody systems.
    Jacobsen C, Steensgaard J.
    Immunology; 1984 Mar 01; 51(3):423-30. PubMed ID: 6698574
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis.
    Kortt AA, Nice E, Gruen LC.
    Anal Biochem; 1999 Aug 15; 273(1):133-41. PubMed ID: 10452809
    [Abstract] [Full Text] [Related]

  • 20. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M, Fogarasi M, Gruber H, Gresch O, Schäfer C, Aguib Y, Skerra A.
    Protein Eng Des Sel; 2009 Mar 15; 22(3):175-88. PubMed ID: 19022801
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.